1 month Mirum (MIRM) Banks on Livmarli, Overdependence a Concern Zacks
Mirum’s (MIRM) lead drug, Livmarli, continues to generate steady sales. The recent label expansion of the drug should drive sales further. However, overdependence on Livmarli for revenues is a concern.